| Members |
targetComponentId |
| Lignocaine hydrochloride+adrenaline 2%/1:200000 sterile wrapped injection |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
| Lignocaine hydrochloride+glucose 5%/7.5% injection |
Lidocaine hydrochloride 50 mg/mL solution for injection |
| Lincomycin 300mg/mL injection |
Lincomycin only product in parenteral dose form |
| linkomycinhydroklorid 300 mg/ml, injektionsvätska, lösning, ampull |
Lincomycin only product in parenteral dose form |
| linezolid 100 mg/5 ml, granulat till oral suspension |
Product containing precisely linezolid 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Linezolid 100mg/5mL granules for oral suspension |
Product containing precisely linezolid 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Linezolid 100mg/5mL suspension |
Product containing precisely linezolid 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| linezolid 2 mg/ml, infusionsvätska, lösning, påse 300 ml |
Product containing precisely linezolid 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Liothyronine sodium preparation |
Product containing liothyronine (medicinal product) |
| Lipoma of spinal column |
Lipoma of spinal cord |
| liposarkom |
Liposarcoma |
| liposomalt daunorubicin 2 mg/ml, injektionsvätska, emulsion |
Product containing only daunorubicin liposome in parenteral dose form (medicinal product form) |
| liposomal doxorubicinhydroklorid 2 mg/ml, infusionskoncentrat, flaska 10 ml |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| liposomal doxorubicinhydroklorid 2 mg/ml, infusionskoncentrat, flaska 25 ml |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Liquid paraffin [eye] |
Product containing mineral oil (medicinal product) |
| Liquid paraffin [laxative] |
Product containing mineral oil (medicinal product) |
| liraglutid 6 mg/ml, injektionsvätska, lösning |
Product containing only liraglutide (medicinal product) |
| lisinoprilallergi |
Non-allergic hypersensitivity to lisinopril |
| Listeria murrayi |
Listeria grayi (organism) |
| litiumkarbonat 300 mg, tablett med modifierad frisättning |
Product containing only lithium carbonate in oral dose form (medicinal product form) |
| litiumkarbonat 300 mg, depåtablett |
Product containing only lithium carbonate in oral dose form (medicinal product form) |
| livedoid vaskulit i nedre extremitet orsakad av varicer på ben |
Livedoid vasculopathy of lower limb due to varicose veins of lower limb (disorder) |
| fixering med dynamiska drag |
Dynamic splinting |
| leverabscess förutom leverabscess orsakad av amöba |
Abscess of liver |
| Liver derivative complex 25.5mg injection |
Liver extract only product |
| leverderivatkomplex 25,5 mg/ml + injektionsvätska, lösning, ampull |
Liver extract only product |
| Living on the street |
Homeless |
| Living organism |
Organism (organism) |
| Living organism category not applicable |
Organism (organism) |
| Living organism not assigned code in SNOMED |
Organism (organism) |
| Living organism not assigned to a scientific category |
Organism (organism) |
| Living organism not identified |
No living organism identified (finding) |
| Lloyd's syndrome |
Autoimmune polyendocrinopathy |
| hummer, livsmedel |
Lobster (substance) |
| Local convulsion |
Partial seizure |
| Local cyst of bone |
Bone cyst |
| Localization-related epilepsy |
Partial seizure |
| lokaliserad vuxenparodontit |
Localized chronic periodontitis |
| Locked twins obstructing labor |
Interlocked twins |
| lomefloxacin 0,3 %, ögondroppar |
Lomefloxacin 3 mg/mL eye solution |
| långt atoniskt anfall |
Atonic seizure (disorder) |
| Long-acting thyroid stimulator |
Thyroid stimulating immunoglobulins |
| Loperamide 2mg oral lyophilisate tablet |
Loperamide hydrochloride 2 mg oral tablet |
| loperamidhydroklorid 1 mg/5 ml, oral sirap |
Product containing precisely loperamide hydrochloride 200 microgram/1 milliliter conventional release oral solution (clinical drug) |
| loperamidhydroklorid 1 mg/5 ml, sockerfri sirap |
Product containing precisely loperamide hydrochloride 200 microgram/1 milliliter conventional release oral solution (clinical drug) |
| loperamidhydroklorid 2 mg, munsönderfallande tablett |
Loperamide hydrochloride 2 mg oral tablet |
| Loperamide hydrochloride+simethicone |
Product containing loperamide and simeticone (medicinal product) |
| Lophortyx gambelii |
Callipepla gambelii (organism) |
| lorakarbef 100 mg/5 ml, oral suspension |
Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Loracarbef 100mg/5mL suspension |
Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| lorakarbef 200 mg/5 ml, oral suspension |
Loracarbef 40 mg/mL oral suspension |
| Loracarbef 200mg/5mL suspension |
Loracarbef 40 mg/mL oral suspension |
| Loracarbef, anhydrous 100mg/5mL powder |
Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Loracarbef, anhydrous 200mg/5 mL powder |
Loracarbef 40 mg/mL oral suspension |
| loratadin 10 mg/10 ml, sirap |
Loratadine 1 mg/mL oral solution |
| loratadin + pseudoefedrinsulfat 5 mg/120 mg, tablett med modifierad frisättning |
Loratadine and pseudoephedrine only product in oral dose form |
| loratadin 5 mg + pseudoefedrinsulfat 120 mg, depåtablett |
Loratadine and pseudoephedrine only product in oral dose form |
| lordos vid höftsjukdom |
Lordosis deformity of spine due to disorder of hip region |
| lordos vid skelettdysplasi |
Lordosis deformity of spine due to congenital skeletal dysplasia |
| lovastatin 10 mg, tablett med modifierad frisättning |
Product containing only lovastatin in oral dose form (medicinal product form) |
| lovastatin 10 mg, depåtablett |
Product containing only lovastatin in oral dose form (medicinal product form) |
| lovastatin 20 mg, tablett med modifierad frisättning |
Product containing only lovastatin in oral dose form (medicinal product form) |
| lovastatin 20 mg, depåtablett |
Product containing only lovastatin in oral dose form (medicinal product form) |
| lovastatin 40 mg, tablett med modifierad frisättning |
Product containing only lovastatin in oral dose form (medicinal product form) |
| lovastatin 40 mg, depåtablett |
Product containing only lovastatin in oral dose form (medicinal product form) |
| lovastatin 60 mg, tablett med modifierad frisättning |
Product containing only lovastatin in oral dose form (medicinal product form) |
| lovastatin 60 mg, depåtablett |
Product containing only lovastatin in oral dose form (medicinal product form) |
| lågt cervikalt kejsarsnitt |
Lower uterine segment caesarean section |
| Low cervical cesarean section |
Lower uterine segment caesarean section |
| Low pressure hydrocephalus |
Normal pressure hydrocephalus |
| Lower uterine segment cesarean delivery NEC |
Lower uterine segment caesarean section |
| Lucilia sericata |
Phaenicia sericata |
| lumbal somatisk dysfunktion |
Somatic dysfunction of lumbar region (finding) |
| Lumbar spine DXA scan |
Dual energy X-ray absorptiometry of lumbar spine (procedure) |
| Lumbar spine DXA scan |
Dual energy X-ray absorptiometry of lumbar spine (procedure) |
| Lumbar spine DXA scan T score |
Dual energy X-ray photon absorptiometry lumbar spine scan T score (observable entity) |
| Lumbar spine DXA scan T score |
Dual energy X-ray photon absorptiometry lumbar spine scan T score (observable entity) |
| Lumbar spine DXA scan Z score |
Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity) |
| Lumbar spine DXA scan Z score |
Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity) |
| Lumbar spine dual energy X-ray absorptiometry scan (procedure) |
Dual energy X-ray absorptiometry of lumbar spine (procedure) |
| T-poäng vid DXA-skanning av ländrygg |
Dual energy X-ray photon absorptiometry lumbar spine scan T score (observable entity) |
| Z-poäng vid DXA-skanning av ländrygg |
Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity) |
| LE-cell |
Lupus erythematosus cell |
| Luteinizing hormone releasing factor |
Gonadotropin releasing factor |
| Luteinizing hormone releasing factor preparation |
Product containing gonadotropin releasing factor (product) |
| Lutropin alfa 75iu injection (pdr for recon)+solvent |
Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| lutropin alfa 75 IE, pulver för beredning av injektionsvätska, + spädningsvätska |
Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| Luy's nucleus (body structure) |
Structure of subthalamic nucleus of Luy (body structure) |
| lymfadenoid struma |
Hashimoto thyroiditis |
| Lymphadenopathy-associated virus, type II (LAV-II) |
Human immunodeficiency virus type 2 |
| lymfangiom |
Benign lymphangioma |
| Lymphocystis disease virus group |
Genus Lymphocystivirus (organism) |
| lymfatisk leukemi, kategori |
Lymphoid leukaemia |
| Lymphoma morphology |
Malignant lymphoma |
| lymfoproliferativ sjukdom |
Lymphoproliferation of uncertain behavior (morphologic abnormality) |
| Lymphosarcoma cell leukemia |
Lymphoid leukaemia |
| Lymphosarcoma cell leukemia |
Lymphoid leukaemia |
| Lymphosarcoma of extranodal AND/OR solid organ site |
Non-Hodgkin's lymphoma (clinical) |
| Lymphosarcoma of intra-abdominal lymph nodes |
Mixed cell type lymphosarcoma of intra-abdominal lymph nodes |
| Lymphosarcoma of intrapelvic lymph nodes |
Non-Hodgkin's lymphoma (clinical) |
| Lymphosarcoma of intrathoracic lymph nodes |
Mixed cell type lymphosarcoma of intrathoracic lymph nodes (disorder) |